Archive for the ‘Drug Developmen’ Category

2nd Annual Pharmaceutical Risk-Sharing & Value-Based Pricing & Reimbursement Models

Monday, February 1st, 2010

Pharmaceutical Risk Sharing

There is clearly an increasing need for more innovative pricing and reimbursement agreements to help to balance the often conflicting objectives of pharmaceutical and medical technology manufacturers, payers, health technology assessors (HTA), physicians and patients. The industry faces a sustained increase in the cost of healthcare and an ever-increasing range of expensive drugs and technologies available as potential therapies.

Clearly, difficult choices need to be made by payers and HTAs about which products receive funding from increasingly restricted healthcare budgets, especially with often insufficient clinical and real-life evidence available. In terms of innovative agreements, more manufacturers, in more countries, are proposing risk-sharing and value-based schemes more often.

NextLevel Pharma has organized a unique meeting that will be focused purely on risk-sharing and value-based pricing schemes and will provide experts theories and practical case studies of successful models.

Why Attend?

  • Understand the opportunities, obstacles and challenges in designing and implementing innovative agreements.
  • Find out when risk-sharing & value-based agreements are required and how they can be designed to satisfy all stakeholders to gain market access.
  • Understand whether or not the turbulent macroeconomic environment will increase payer motivation for flexible agreements.
  • Obtain the best and most focused picture of risk-sharing and value-based pricing models today.
  • Learn how drug effectiveness is being demonstrated in different regions.
  • Understand the best ways to communicate value and achieve maximum patient and market access.
  • Hear the perspectives of all stakeholder groups: Payers, regulators, insurers, health economists and the pharmaceutical industry.
  • Discover how payers are evaluating conditional reimbursement agreements.

  • Who should attend?
    Pharmaceutical companies:

  • Vice-Presidents, Directors, Managers involved in:
  • Pricing & Reimbursement,
  • Market Access,
  • Health Economics & Outcomes,
  • Government & Stakeholder Relations,
  • Regulatory Affairs,
  • Medical Affairs,
  • Marketing & Commercial,
  • Therapy Area Heads,
  • Country Managers,
  • Business Unit Heads
  • Solution providers & consultants:
  • CEOs,
  • Business Development,
  • Senior Consultants,
  • Regional Heads.
  • Independent Academics, Health Economists, Senior Doctors, & Patient Representatives.

  • Agenda request
    To request the full agenda please follow the link:
    2nd Annual Pharmaceutical Risk-Sharing & Value-Based Pricing & Reimbursement Models

    For Booking Information contact:
    Erika Vavrovicova
    Tel: +421 232 660 382
    Fax: +421 232 660 397
    Email: erika@nextlevelpharma.com
    Visit: www.nextlevelpharma.com

    Enhancing Performance of Early Phase Drug Development Projects

    Monday, February 1st, 2010

    Early Phase Drug

    The pharmaceutical industry is constantly facing increasing demands for efficiency and cost effectiveness, making the development of project management skills and tools combined with their flawless application critical to deliver the best chance of success for a new compound. A well planned and executed project is vital in ensuring the speedy collection of critical data to judge efficacy, safety and the value of progressing the drug candidate to the next level.

    However, in drug development it’s a constant challenge to identify early on the best candidates and strategic approaches to achieve proof-of-concept and minimize attrition likelihood in p.III. As drug development becomes increasingly globalised, unexpected delays combined with requests for further studies and communication failure can prevent the timely completion of a project.

    Enhancing Performance of Early Phase Drug Development” will look to examine the current state of project management approaches during pre-clinical to phase II and the improvements that can be made in planning, implementing, and controlling pharma project components. By developing these areas biopharma companies and project teams will be able to minimize the risks associated with a new drug’s development, and better reach go/ no go decisions in both small and large molecule drugs.

    Why Attend?

    This conference will cover how to decide upon early phase research strategies, and the operational project management tools and techniques to be best used:

  • Improve strategic decision making to enable multiple project successes.
  • Minimise risks generated by advancing a compound’s development
  • Learn how to execute projects involving varied early phase & remote stakeholders, both internally and externally.
  • Clarify project scope & team responsibilities to enable optimum allocation of resources.
  • Define project management tools and techniques to better leverage early stage research
  • Build effective project teams involving both internal and external resources.
  • Who will benefit?
    Project Managers and those individuals with project responsibilities in early phase Development
    VPs, Senior Directors and Managers of:
    o Discovery,
    o pre-clinical development,
    o exploratory development,
    o early phase clinical development,
    o clinical science,
    o clinical operations,
    o clinical pharmacology & PK/ PD, drug safety,
    o biomarkers,
    o translational medicine,
    o adaptive research,
    o regulatory affairs,
    o therapy area heads & specialists,

    Agenda request
    To request the full agenda please follow the link:

    www.nextlevelpharma.com/events/request_agenda/enhancing_performance_of_early_phase_drug_development_projects
    For Booking Information contact:
    Erika Vavrovicova

    Tel: +421 232 660 382
    Fax: +421 232 660 397
    Email: erika@nextlevelpharma.com
    Visit: www.nextlevelpharma.com

    Webinar Series: Safety Biomarkers in Drug Development

    Friday, August 7th, 2009

     

     

    The ability to accurately predict adverse events related to areas like cardiology, nephrology, neurology, haematology and hepatology is extremely exciting. Validated safety biomarkers provide the opportunity for smarter and earlier decision making in R&D, meaning project „kill“ decisions are made quicker, later-stage projects become less risky and hundreds of millions of dollars can be saved.

    This webinar will summarise what are the most innovative recent scientific developments and the most promising regulatory initiatives, as well as providing a platform for partnering amongst the pharma, biotech, diagnostics and academic sectors.

    Why attend?

     

    • Understand the regulatory requirements to demonstrate safety through biomarkers.
    • Make partnerships and alliances with biomarker R&D experts.
    • Gain access to the latest successful biomarker development case studies.
    • Review multi-stakeholders perspectives: pharma, regulators, research institutes, academia & solution providers.
    • Learn how to integrate biomarker knowledge in monitoring safety in drug development to reduce risk.
    • Identify and understand better, advanced cardiac, renal, hepatological and neurological risk markers.
    • Discover cutting-edge approaches for identification and development of new markers.

    Who will benefit:

    Pharmaceutical, Biotech, Diagnostic & Academic research organisations:
    CEOs / Vice-Presidents / Heads / CSOs / Managers / Professors and Scientists involved in: R&D, drug safety & pharmacovigilance, biomarker discovery/validation, molecular diagnostics, pharmacogenomics/genetics/proteomics, translational medicine, clinical science and development, molecular imaging, pre-clinical development, modeling and simulation, pharmacology, pharmacokinetics/pharmacodynamics

    Solution providers & consultants:
    CEOs, Business Development, Senior Consultants, Regional Heads

     

    Agenda Request

    To request the full agenda please follow the link:

    https://www.nextlevelpharma.com/events/request_agenda/safety_biomarkers_in_drug_development

    Contact Details:

    For Booking Information:

    Tel: +421 232 662 621

    Fax: +421 232 660 395
    Email: erika@nextlevelpharma.com

    Visit: www.nextlevelpharma.com

    Next Generation Sequencing (NGS)Congress on November 2009

    Wednesday, August 5th, 2009

      • Next Generation Sequencing High Throughput Sequencing Platforms: Implementation and Technology Considerations
        Sequencing Applications Considerations
      • Applying Next-Generation Sequencing to Cancer and Medical Genetics and Discovery Research
      • Next Generation Sequencing Technologies and Bioinformatic Analysis Tools
      • Data Analysis
      • Data Management and Storage Strategies
    • Oxford Global Conferences is proud to present Next Generation Sequencing (NGS)Congress, which is to be held on the 16th & 17th November 2009 in London. The congress is held in conjunction with qPCR Congress( www.qpcr-congress.com).

       

      Next-generation sequencing technologies are revolutionizing biology by allowing for genome-wide transcription factor binding-site profiling, transcriptome sequencing, and more recently, whole-genome resequencing. These technologies will provide a genome-wide sequence readout as an endpoint to applications ranging from chromatin immunoprecipitation, mutation mapping and polymorphism discovery to noncoding RNA discovery.

       

      Over the 2 days, the conference provides an overview of the current options of next-generation sequencing platforms, technologies, applications and the newest computational tools for the analysis of next-generation sequencing data.

       

      The event will attract over 120 senior-level decision makers working in bioinformatics & data management, next generation sequencing, discovery, RNA profiling, molecular genomics, and clinical & diagnostics development from the UK, Europe and US.  This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.

       

      THE EVENT

      In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 25 speakers will present a full conference programme covering the following key topics include:

       

      Day 1 – 16th November

       

      Day 2 – 17th November

       

      WHO ATTENDS?

      Delegates are pre-qualified dependent on budget, responsibility and seniority.  Delegates are senior-level decision makers, from major pharmaceutical, biotech companies and research institutions based in Europe and typically include VPs, Directors, Managers and Heads of:

      Drug Discovery

      High throughput Technologies

      Bioinformatics

      Data Management

      Principal Investigation

      Molecular Profiling/Diagnostics

      Clinical Development

      qPCR

      Next Generation Sequencing

      Gene Expression

      Biostatistics

      Genomics

       

      YOUR NETWORKING OPPORTUNITIES

      Meet face-to-face with leading solution providers and senior-level industry peers through a series of formal and informal networking opportunities.  Using our online appointment system, you are able to view the full profiles of all solution provides before the event. In addition you have the chance to pre-arrange one-to-one meetings with them, giving you the opportunity to discuss technologies, services and solutions that address your key business needs.   Categories of solution providers include:

       

      Next Generation Sequencing Platforms

      NGS technologies

      Screening Technologies

      High Throughput Sequencing

      Data Management Methods

      Bioinformatics/Biostatistics Solutions

       

       

      Special discounts are available by quoting NGSDEL09. For information on sponsorship and registration please email info@oxfordglobal.co.uk or call +44(0) 1865 304925 www.nextgenerationsequencing-congress.com.

       

       

    Medifest, premier medical & healthcare techno trade fair in Pragati INDIA

    Tuesday, August 4th, 2009

     

     

     

    Register for Medifest’09, a not to be missed opportunity to explore Indian Healthcare Market 

    Medifest’ 09, Premier Medical & Healthcare Techno Trade Event, is scheduled to be held at Pragati Maidan, New Delhi, India from December 11-13, 2009.  Medifest provides a unique opportunity for all related to medical field to reach new horizons of effective cooperation and discuss vital issues that stand presently in front of medicine and healthcare industry.

    Dedicated Segments:-

    Medifest’ 09 will be having exclusive and dedicated segments on

    • Medical & Healthcare Devices

    • Pharmaceuticals

    • Lab & Diagnostics

    • Dental Products

    Participation Tarrif:-

    Exhibition Space Min. Area USD

    Exhibitor Profile:-

    Medical Technology
    Pharmaceutical Manufacturers
    Healthcare Informatics
    Medical Consumables
    Disposables
    Diagnostic Kits
    Reagents
    Healthcare Products
    Nutritional Products
    Dietary Products
    Medical Process Equipment
    Labware
    Optical Equipment
    Surgical Tools
    Personal Hygiene Products

    Medical Publication and Services
    First Aid Equipment
    Clothes and Linen
    Rehabilitative Products
    Educational Equipments
    Bio-Tech Products
    Nursing Care Products
    Natural Products
    Herbal Healthcare Products
    Mother Care
    Homeopathic Preparations
    Electromedical Equipment
    Diagnostics
    Lab Equipment
    Dental Products

     

     

    Visitor Profile:-

    Medical and Paramedical Fraternity
    Doctors,Scientists,Nurses,Paramedics and all other related
    Health Organizations
    Hospitals(International,National State Hospitals)
    Manufacturing Houses
    Pharmaceutical Houses
    Research and Development Organizations
    Govt. Agencies
    Ministries of Health Department
    Embassies
    Medical Institutes
    Public Health Services
    Importers
    Distributors
    Retailers

    Our previous clients say about us:-  

     

    It was an excellent show. This was the first time that we participated in an exhibition and the response was enormous. We would definitely participate next time.

    Mr. Nitin Raj – Marketing Head – Primus Gloves Private Limited – India

     

     It was nice to participate in this exhibition and we had a very good footfall. The organizer’s cooperative attitude is admirable.

    Mrs. K. Verma – Director – ATS International – Korea 

     

    We are participating for the second year at Medifest. We got good business and will be there with you next year as well.

     Mr. Jose E.S. – CEO – Coresys Infotech – India

     

    We are very happy and satisfied. We got a lot of very good contacts. Good news! We found exclusive distributors for our products in India

    Mr. Marc Moneaux - International Sales & Relations - Grena Ltd – UK

     

    We got a good feedback from potential customers and hence this meeting is really a success for our  company.

    Mr. Bogaert JP - PresidentBonyf AG – Liechtenstein

    Register now to avail on-going offers:-

    ~ Free advertisement in Medifest Buyer’s Guide*~ Be a part of exclusive promotional campaign for initial business discussions with pre-identified distributors and have face to face  interaction during Medifest*

       (*Conditions Apply)

    For any kind of assistance, mail us at medifest@gmail.com

     Thanks & Regards

     Team Medifest

    (contact@vantagetradefairs.com)

     

    qPCR Congress 2009 in UK this November

    Sunday, August 2nd, 2009

      • Successful Gene Expression Analysis using real-time PCR
      • Profiling technologies: multivariate and multiway expression profiling, temporal expression profiling and spatiotemporal maps
      • Other technologies: High resolution melt, Immuno PCR, Methylation sensitive PCR, SNP analysis, microRNA detection and Multiplex technologies
      • Development of clinical diagnostics and clinical Development – use in therapeutic areas such as cancer and infectious diseases
      • Bioinformatics
      • Data management: software applications, data mining, data visualization, biostatistics, multivariate statistics
      • Assay optimisation and validation strategies
      • New applications of qPCR- High throughput applications, Real-time RT-PCR arrays and Digital PCR
      • The discovery of Biomarkers: Disease markers, Tissue specific markers, Cancer markers, Stem cells, Differentiation markers and Cancer stem cells
      • The potential and use of qPCR reagents and instrumentation
    • Oxford Global Conferences is proud to present qPCR Congress 2009 (www.qpcr-congress.com), which is to be held on the 16th & 17th November 2009 in London. The congress is the single most focused event in Europe dedicated to key technological and scientific trends & advances in qPCR in the pharmaceutical and biotech industry, as well as academic institutions. There is also a post conference workshop on Biostatistics on the 18th November.

       

      This conference explores effective strategies, technologies and applications of qPCR in accelerating drug discovery and the development of clinical diagnostics. Over three days, the event will attract over 120 senior-level decision makers working in discovery, biomarkers, gene expression, molecular biology, and clinical & diagnostics development and bioinformatics & data management from the UK, Europe and US.  This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.

       

      THE EVENT

      In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 45 speakers will present a full conference programme covering the following key topics include:

       

      Day 16th November

      Stream 1: qPCR in Diagnostics and Molecular Markers as well as Novel Technical Approaches

      Stream 2: Bioinformatics and Data Management

      Day 2 17th November

      Stream 1: qPCR in Drug Discovery and Development

      Stream 2: Next Generation Sequencing High Throughput Sequencing Platforms

       

      Day 3 18th November: Post Conference Workshop – Biostatistics

       

      WHO ATTENDS?

      Delegates are pre-qualified dependent on budget, responsibility and seniority.  Delegates are senior-level decision makers, from major pharmaceutical, biotech companies and research institutions based in Europe and typically include VPs, Directors, Managers and Heads of:

       

      Drug Discovery

      Biomarkers

      Bioinformatics

      Clinical Diagnostics

      Principal Investigators

      Molecular Profiling

      Clinical Development

      qPCR

      Gene Expression

       

       

       

      Toxicology

      Translational Science

      Biochemistry

      Genomics

      Biostatistics

      High throughput Technologies

      Data Management

      Cell Biology

       

      YOUR NETWORKING OPPORTUNITIES

      Meet face-to-face with leading solution providers and senior-level industry peers through a series of formal and informal networking opportunities.  Using our online appointment system, you are able to view the full profiles of all solution provides before the event.  In addition you have the chance to pre-arrange one-to-one meetings with them, giving you the opportunity to discuss technologies, services and solutions that address your key business needs.  Categories of solution providers include:

       

      Real-Time PCR Reagents & Instrumentation

      qPCR technologies

      Screening Technologies

      Gene Expression Services

      RNAi Applications

      Bioinformatics/Biostatistics Solutions

      Molecular & Expression Profiling

      High Throughput Sequencing

      Data Management Methods

      Multiplex Technologies

      Sampling Technologies

      Multimarker Diagnostics

       

       

      Special discounts are available by quoting qPCRDEL09. For information on sponsorship and registration please email info@oxfordglobal.co.uk or call +44(0) 1865 304925 www.qpcr-congress.com.